Showing 1 - 4 results of 4 for search '"Tom Walter"', query time: 0.18s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects by Hosseini K, Gollamudi S, Reiser H, Walters T, Lindstrom RL

    Published 2023-08-01
    “…Kamran Hosseini,1 Subba Gollamudi,2 Harvey Reiser,3 Tom Walters,4 Richard L Lindstrom5 1Surface Ophthalmics, Pleasanton, CA, USA; 2VRF Eye Specialty Group, Memphis, TN, USA; 3Eye Care Specialists, Kingston, PA, USA; 4Texan Eye, PA — Keystone Research, Austin, TX, USA; 5Minnesota Eye Consultants, Bloomington, MN, USACorrespondence: Kamran Hosseini, Surface Ophthalmics, Inc, 5000 Hopyard Road, Ste. 402, Pleasanton, CA, 94588, USA, Email khosseini@surfaceophthalmics.comPurpose: To compare the preservative-free corticosteroid 0.2% betamethasone sodium phosphate BID (SURF-201) to vehicle BID in patients undergoing routine cataract surgery.Methods: Phase 2, multicenter, randomized (1:1 ratio), double-masked, vehicle-controlled, parallel-group study in patients scheduled for uncomplicated cataract surgery without the aid of a femtosecond laser. …”
    Get full text
    Article